| Total sample n = 52 | Men n = 32 | Women n = 20 | p-value |
---|---|---|---|---|
Age at infection, years | Â | Â | Â | Â |
    Mean (SD) | 62.9 (11.0) | 62.3 (8.3) | 63.7 (14.6) | 0.579 |
    Median (min-max) | 63.5 (31–93) | 63.5 (43–77) | 64.0 (31–93) |  |
BMI | Â | Â | Â | Â |
    Mean (SD) | 29.5 (6.2) | 30.1 (5.2) | 28.6 (7.7) | 0.096 |
    Median (min-max) | 28.6 | 29.0 | 26.1 |  |
 | (18.7–51.4) | (19.0–44.8) | (18.7–51.4) |  |
Length of stay, days | Â | Â | Â | Â |
    Median (min-max) | 22 (5–175) | 23 (5–175) | 22.0 (6–90) | 0.351 |
Need of ICU care | Â | Â | Â | Â |
    Yes (%) | 31 (60) | 21 (66) | 10 (50) | 0.384 |
    No (%) | 21 (40) | 11 (34) | 10 (50) |  |
Intubated | Â | Â | Â | Â |
    Yes (%) | 21 (40) | 15 (47) | 6 (30) | 0.247 |
    No (%) | 31 (60) | 17 (53) | 14 (70) |  |
If yes, intubated, days (%) | Â | Â | Â | Â |
    1–5 | 3 (14) | 2 (13) | 1 (17) | 0.029 |
    6–10 | 4 (20) | 1 (6) | 3(49) |  |
    11–15 | 1 (5) | 0 | 1 (17) |  |
    16–20 | 3 (14) | 2 (13) | 1 (17 |  |
    21–30 | 3 (14) | 3 (20) | 0 |  |
    > 31 | 6 (28) | 6 (40) | 0 |  |
    Unclear | 1 (5) | 1 (6) | 0 |  |
HFNC/Optiflow, days (%) | Â | Â | Â | Â |
    Yes | 35 (67) | 23 (72) | 12 (60) | 0.953 |
    No | 14 (27) | 7 (22) | 7 (35) |  |
    Unclear | 3 (6) | 2 (6) | 1 (5) |  |
Tracheostomy, days (%) | Â | Â | Â | Â |
    Yes | 14 (27) | 12 (38) | 2 (10) | 0.026 |
    No | 38 (73) | 20 (62) | 18 (90) |  |
Pulmonary disease’ |  |  |  |  |
    In total | 15 | 8 | 7 | 0.534 |
    COPD | 7 | 2 | 2 |  |
    Asthma | 8 | 5 | 3 |  |
    Sarcoidosis | 1 | 1 | 0 |  |
Smoker | Â | Â | Â | Â |
    Yes (%) | 4 | 1 | 3 | 0.235 |
    No (%) | 23 | 16 | 7 |  |
    Former smoker (%) | 25 | 5 | 9 |  |
Physical activity prior Covid-19 infection (SGPALS) | Â | Â | Â | Â |
    Physically inactive, n (%) | 17 (33) | 10 (31) | 7 (35) | 0.594 |
    Light physical activity, n (%) | 22 (42) | 13 (41) | 9 (45) |  |
    Moderate physical activity, n (%) | 13 (25) | 9 (28) | 4 (20) |  |
    Vigorous physical activity, n (%) | 0 (0) | 0 (0) | 0 (0) |  |
3 months post discharge |  | |||
Phone follow-up, days median (min-max) since discharge | 94 (74–131) | 92.5 (76–119) | 95 (74–131) |  |
CAT | Â | Â | Â | Â |
    Total score median, (mi-max) | 18 (6–39) | 32 (6–39) | 22 (8–32) | 0.199 |
    Cough | 2 (0–5) | 2 (0–5) | 2 (0–4) |  |
    Mucus | 2 (0–5) | 2 (0–5) | 1 (0–4) |  |
    Chest tightness | 2 (0–5) | 2 (0–5) | 3 (0–5) |  |
    Dyspnoea during activity | 4 (1–5) | 4 (1–5) | 4 (2–5) |  |
    Limitations at home | 3 (0–5) | 2 (0–5) | 3 (0–5) |  |
Physical activity (SGPALS) | Â | Â | Â | Â |
    Physically inactive, n (%) | 17 (33) | 8 (25) | 9 (45) | 0.153 |
    Light physical activity, n (%) | 23 (44) | 15 (47) | 8 (40) |  |
    Moderate physical activity, n (%) | 10 (19) | 7 (22) | 3 (15) |  |
    Vigorous physical activity, n (%) | 2 (4) | 2 (6) | 0 (0) |  |
PCFS | Â | Â | Â | Â |
    Severe limitations | 2 | 1 | 1 | 0.075 |
    Moderate limitations | 7 | 3 | 4 |  |
    Slight limitations | 14 | 7 | 7 |  |
    Negligible limitation | 14 | 18 | 4 |  |
    No limitations | 22 6 | 3 | 3 |  |